NA
Navidea Biopharmaceuticals, Inc.
NAVBQ · OTC
$0.00 -99.75% (-$0.04)
1M +0.00%
Market Cap $10.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.15x
PEG N/A
P/E N/A
Growth
100 /100
Growing Rev. growth 35.11%
Book val. growth N/A
EPS growth N/A
Profitability
0 /100
Weak Op. margin 21,402.10%
Gross margin 259.40%
FCF margin 14,282.80%
Quality
57 /100
Average Asset turnover 0.02x
ROIC 280.59%
ROA 347.18%
Debt
50 /100
Moderate Net debt/EBITDA -0.03x
Current ratio 0.32x
Int. coverage -12.82x
Stability
28 /100
Unstable EPS volatility 39.84%
Beta -4.82x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NAVBQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig A. Dais
Employees
11
Headquarters
Dublin
Upcoming events
16 NOV
Earnings
Upcoming earnings report